Details of the Drug

General Information of Drug (ID: DM5J0H3)

• Drug Name: Propan-2-one O-4-(hexyloxy)phenylcarbamoyl oxime
• Synonyms: CHEMBL597088; propan-2-one O-4-(hexyloxy)phenylcarbamoyl oxime

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

• Drug Type: Small molecular drug
• #Ro5 Violations (Lipinski): 0:
  Molecular Weight (mw); 292.37
  Logarithm of the Partition Coefficient (xlogp); 4
  Rotatable Bond Count (rotbonds); 9
  Hydrogen Bond Donor Count (hbonddonor); 1
  Hydrogen Bond Acceptor Count (hbondacc); 4
• Chemical Identifiers:
  Formula: C16H24N2O3
  IUPAC Name: (propan-2-ylideneamino) N-(4-hexoxyphenyl)carbamate
  Canonical SMILES: CCCCCCOC1=CC=C(C=C1)NC(=O)ON=C(C)C
  InChI: InChI=1S/C16H24N2O3/c1-4-5-6-7-12-20-15-10-8-14(9-11-15)17-16(19)21-18-13(2)3/h8-11H,4-7,12H2,1-3H3,(H,17,19)
  InChIKey: OTUAPVMKCJEVBD-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 20872820
  TTD ID: D02DKM

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Fatty acid amide hydrolase (FAAH)	TTDP1UC	NOUNIPROTAC	Inhibitor	[1]

Molecular Expression Atlas of This Drug

• The Studied Disease: Discovery agent
• ICD Disease Classification: N.A.

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Fatty acid amide hydrolase (FAAH)	DTT	NO-GeName	2.65E-01	0.02	0.1

References

• [1] Oxime carbamate--discovery of a series of novel FAAH inhibitors. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1272-7.